{"id":"W2012293370","doi":"10.1111/all.12148","title":"Double‐blind, placebo‐controlled, dose‐ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber","year":2013,"lang":"en","type":"article","venue":"Allergy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"ca_institutions":"Inflamax Research (Canada)","funders":"Allergopharma; European Academy of Allergy and Clinical Immunology","keywords":"Hypoallergenic; Tolerability; Placebo; Medicine; Adverse effect; Dose-ranging study; Allergy; Internal medicine; Gastroenterology; Allergen; Immunology; Double blind; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009792481,0.000815366,0.002129436,0.0002428304,0.0002757293,0.0003651987,0.0006098987,0.0009126799,0.002605939],"category_scores_gemma":[0.0006301146,0.0003769982,0.000565294,0.0002105841,0.0008868171,0.0004559928,0.0002619335,0.001625962,0.0004900593],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002426771,"about_ca_system_score_gemma":0.0004476919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002435817,"about_ca_topic_score_gemma":0.0004530138,"domain_scores_codex":[0.9996119,0.0001505213,0.00003376884,0.00008163387,0.00005246472,0.00006978294],"domain_scores_gemma":[0.9995371,0.0001236433,0.0001043927,0.00005131058,0.00003564033,0.0001478945],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8887524,0.03907134,0.001154718,0.0005276192,0.0004575024,0.00005212606,0.000081823,0.0004153584,0.04512033,0.0000644298,0.0003432712,0.02395915],"study_design_scores_gemma":[0.4300908,0.5576037,0.006131832,0.00001954174,0.0002716762,0.00006550437,0.00002364945,0.0003882809,0.00462532,0.0000447114,0.000720033,0.00001487809],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972658,0.001017774,0.0003567965,0.00006145504,0.0001066752,0.0006981554,0.0001316046,0.00003551048,0.0003263727],"genre_scores_gemma":[0.9942659,0.0009168594,0.001140071,0.0002837355,0.0002013936,0.001665601,0.0002939538,0.000009324539,0.001223132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002605939,"threshold_uncertainty_score":0.008717775,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02817648615096423,"score_gpt":0.2613910049618025,"score_spread":0.2332145188108383,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}